← Back to Clinical Trials
Recruiting NCT07278622

NCT07278622 Virtual Group Prehabilitation Education (Surgery School) Feasibility Trial

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07278622
Status Recruiting
Phase
Sponsor University Hospital Southampton NHS Foundation Trust
Condition Cancer Surgery
Study Type INTERVENTIONAL
Enrollment 24 participants
Start Date 2025-09-02
Primary Completion 2026-07-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
GoPREPARE

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 24 participants in total. It began in 2025-09-02 with a primary completion date of 2026-07-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

One in four patients requiring planned major surgery have complications. Prehabilitation; which involves increasing physical activity, improving nutrition and supporting emotional well-being prior to surgery can reduce these complications and improve recovery. Group preoperative prehabilitation classes (surgery schools) are advocated by the Centre for Perioperative Care and are standard care in many hospitals, despite a lack of evidence for their effectiveness in improving patient outcomes. In phase 1 an 2 of this research investigators used patient experiences and co-participatory methods to optimise an existing intervention to make it as acceptable and as engaging as possible. The resulting education package is called 'GoPREPARE' Investigators now intend to test the practicalities of trialing GoPREPARE on preoperative patients with cancer. 24 patients awaiting surgery will be recruited from University Hospital Plymouth and randomly allocated equally to: Group - GoPREPARE and Group 2- standard care. Participants will complete lifestyle questionnaires before during and after their hospital stay. To evaluate the experience, \~8 participants will be interviewed. 5 clinical staff involved in the trial will also take part in a focus group. The information collected will be analysed to assess if it is feasible to conduct a larger trial.

Eligibility Criteria

Inclusion Criteria: * Adults undergoing elective surgery for any body cavity cancer with curative intent. * Adults with more than 3 weeks before planned surgery * Adults without previous experience of prehabilitation. Exclusion Criteria: * Children * Adults who lack mental capacity. * Adults who do not understand spoken English. * Previous experience of prehabilitation. * Previous surgery for cancer * Pregnancy

Contact & Investigator

Central Contact

Imogen C Fecher-Jones, MSc

✉ Imogen.fecher@uhs.nhs.uk

📞 +447590270743

Principal Investigator

Denny Z Levett, PhD

STUDY DIRECTOR

Universal Hospital Southampton NHS Foundation Trust

Frequently Asked Questions

Who can join the NCT07278622 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07278622 currently recruiting?

Yes, NCT07278622 is actively recruiting participants. Contact the research team at Imogen.fecher@uhs.nhs.uk for enrollment information.

Where is the NCT07278622 trial being conducted?

This trial is being conducted at Plymouth, United Kingdom.

Who is sponsoring the NCT07278622 clinical trial?

NCT07278622 is sponsored by University Hospital Southampton NHS Foundation Trust. The principal investigator is Denny Z Levett, PhD at Universal Hospital Southampton NHS Foundation Trust. The trial plans to enroll 24 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology